Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,652 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human assembloid model of the ascending neural sensory pathway.
Kim JI, Imaizumi K, Thete MV, Hudacova Z, Jurjuţ O, Amin ND, Scherrer G, Paşca SP. Kim JI, et al. bioRxiv [Preprint]. 2024 Mar 12:2024.03.11.584539. doi: 10.1101/2024.03.11.584539. bioRxiv. 2024. PMID: 38559133 Free PMC article. Preprint.
Assembloid model to study loop circuits of the human nervous system.
Miura Y, Kim JI, Jurjuț O, Kelley KW, Yang X, Chen X, Thete MV, Revah O, Cui B, Pachitariu M, Pașca SP. Miura Y, et al. Among authors: kim ji. bioRxiv [Preprint]. 2024 Oct 14:2024.10.13.617729. doi: 10.1101/2024.10.13.617729. bioRxiv. 2024. PMID: 39463945 Free PMC article. Preprint.
Simultaneous Epigenetic and Gene Expression Profiling at Single Cell Resolution Uncovers Stem-Like Treg Subsets Induced With Oligonucleotide Expansion in Humans.
Nam HJ, Gong JR, Kim YH, Nguyen-Phuong T, Byun N, Yoon JH, Kim YC, Chung H, Lee BH, Kwon H, Lee W, Kang SJ, Park K, Cha B, Kim JI, Kim HJ. Nam HJ, et al. Among authors: kim ji. Immune Netw. 2024 Oct 24;24(6):e39. doi: 10.4110/in.2024.24.e39. eCollection 2024 Dec. Immune Netw. 2024. PMID: 39801740 Free PMC article.
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, Ogasawara S, Kim JH, Zhao H, Li C, Madoff DC, Ghobrial RM, Kawaoka T, Gerolami R, Ikeda M, Kumada H, El-Khoueiry AB, Vogel A, Peng X, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS, Llovet JM; LEAP-012 investigators. Kudo M, et al. Lancet. 2025 Jan 8:S0140-6736(24)02575-3. doi: 10.1016/S0140-6736(24)02575-3. Online ahead of print. Lancet. 2025. PMID: 39798578
9,652 results